These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18923799)

  • 1. Use of peak expiratory flow for assessing bronchodilator responsiveness.
    Aggarwal AN; Agarwal R; Gupta D; Jindal SK
    Prim Care Respir J; 2009 Mar; 18(1):50-2. PubMed ID: 18923799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV(1) in primary care patients presenting with a persistent cough?
    Thiadens HA; De Bock GH; Van Houwelingen JC; Dekker FW; De Waal MW; Springer MP; Postma DS
    Thorax; 1999 Dec; 54(12):1055-60. PubMed ID: 10567623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic and screening capacities of peak expiratory flow measurements in the assessment of airway obstruction and bronchodilator response in children with asthma.
    Slieker MG; van der Ent CK
    Monaldi Arch Chest Dis; 2003; 59(2):155-9. PubMed ID: 14635506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Logistic regression model for prediction of airway reversibility using peak expiratory flow.
    Shakeri J; Paknejad O; Moghadam KG; Taherzadeh M
    Tanaffos; 2012; 11(1):49-54. PubMed ID: 25191401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peak expiratory flow is not a quality indicator for spirometry: peak expiratory flow variability and FEV1 are poorly correlated in an elderly population.
    Hegewald MJ; Lefor MJ; Jensen RL; Crapo RO; Kritchevsky SB; Haggerty CL; Bauer DC; Satterfield S; Harris T
    Chest; 2007 May; 131(5):1494-9. PubMed ID: 17400677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of the peak expiratory flow in bronchodynamic tests.
    Pino JM; García-Río F; Prados C; Alvarez-Sala R; Díaz S; Villasante C; Villamor J
    Allergol Immunopathol (Madr); 1996; 24(2):54-7. PubMed ID: 8933890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchodilator Response in FVC Is Larger and More Relevant Than in FEV
    Quanjer PH; Ruppel GL; Langhammer A; Krishna A; Mertens F; Johannessen A; Menezes AMB; Wehrmeister FC; Perez-Padilla R; Swanney MP; Tan WC; Bourbeau J
    Chest; 2017 May; 151(5):1088-1098. PubMed ID: 28040521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta2-adrenergic receptor haplotype and bronchodilator response to salbutamol in patients with acute exacerbations of COPD.
    Mokry M; Joppa P; Slaba E; Zidzik J; Habalova V; Kluchova Z; Micietova L; Rozborilova E; Salagovic J; Tkacova R
    Med Sci Monit; 2008 Aug; 14(8):CR392-8. PubMed ID: 18667995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative functional criteria to assess airflow-limitation reversibility in asthma.
    Tavares e Castro A; Matos P; Tavares B; Matos MJ; Segorbe-Luís A
    Rev Port Pneumol (2006); 2015; 21(2):69-75. PubMed ID: 25926369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
    Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Salbutamol in Mixed Obstructive and Restrictive Pattern Spirometry.
    Tuladhar LR; Tamrakar Tuladhar ET
    Kathmandu Univ Med J (KUMJ); 2017 Oct.-Dec.; 15(60):279-283. PubMed ID: 30580341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of asthma in adolescents and young adults: which objective measure is best?
    Ulrik CS; Postma DS; Backer V
    J Asthma; 2005 Sep; 42(7):549-54. PubMed ID: 16169787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peak expiratory flow monitoring and airway response to specific bronchial provocation tests in asthmatics.
    Moscato G; Dellabianca A; Paggiaro P; Bertoletti R; Corsico A; Perfetti L
    Monaldi Arch Chest Dis; 1993; 48(1):23-8. PubMed ID: 8472058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction.
    Dekker FW; Schrier AC; Sterk PJ; Dijkman JH
    Thorax; 1992 Mar; 47(3):162-6. PubMed ID: 1519192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled procaterol versus salbutamol in bronchial asthma.
    Liippo K; Silvasti M; Tukiainen H
    Eur J Clin Pharmacol; 1991; 40(4):417-8. PubMed ID: 1828765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of spacers in asthma.
    Dahiya B; Mathew JL; Singh M
    Indian J Pediatr; 2007 Jul; 74(7):631-5. PubMed ID: 17699970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction.
    Barros MJ; Rees PJ
    Respir Med; 1990 Sep; 84(5):371-5. PubMed ID: 2147295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease.
    de Jong JW; Koëter GH; van der Mark TW; Postma DS
    Thorax; 1996 Jul; 51(7):684-8. PubMed ID: 8882073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which index of peak expiratory flow is most useful in the management of stable asthma?
    Reddel HK; Salome CM; Peat JK; Woolcock AJ
    Am J Respir Crit Care Med; 1995 May; 151(5):1320-5. PubMed ID: 7735580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved criterion for assessing lung function reversibility.
    Ward H; Cooper BG; Miller MR
    Chest; 2015 Oct; 148(4):877-886. PubMed ID: 25879725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.